MXCT R&D to Revenue
Maxcyte Inc · R&D to Revenue
MXCT R&D to Revenue
Latest reported63.05%period ending
MXCT FY R&D/Revenue (43.62% → 63.05%)
Latest values, visible window
High-resolution chart · PNG
MXCT r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 63.0503% | |
| 57.5427% | |
| 57.685% | |
| 44.0885% | |
| 45.4572% | |
| 67.7705% | |
| 81.3679% | |
| 67.4627% | |
| 80.6922% | |
| 38.277% | |
| 32.3789% | |
| 34.758% | |
| 32.5569% | |
| 43.617% |